Back to BCRX

Rosalind Advisors, Inc. → BCRX

Rosalind Advisors, Inc. BCRX Position History

BioCryst Pharmaceuticals, Inc. • Healthcare

Quarters held
3
Latest value
$6M
Q3 2026
Peak value
$8.8M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$8.8M
Q2 2026$7.2M
Q3 2026$6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$6M721.5K——
Q2 2026$7.2M721.5K——
Q1 2026$8.8M923.1K——

Other funds holding BCRX

Other Rosalind Advisors, Inc. positions

DCTH

DELCATH SYSTEMS, INC.

$52.7M
DCTH

DELCATH SYSTEMS, INC.

$41.6M
FENC

FENNEC PHARMACEUTICALS INC

$34.3M
VSTM

VERASTEM INC

$34.1M
FENC

FENNEC PHARMACEUTICALS INC

$34M
DCTH

DELCATH SYSTEMS, INC.

$33M
DCTH

DELCATH SYSTEMS, INC.

$30.6M
XERS

XERIS BIOPHARMA HOLDINGS INC

$24.7M